Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study

Risperidone is routinely used in the clinical management of schizophrenia, but the treatment response is highly variable among different patients. The genetic underpinnings of the treatment response are not well understood. We performed a pharmacogenomic study of the treatment response to risperidon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mingzhe, Ma, Jingsong, Li, Mo, Zhu, Wenli, Zhou, Wei, Shen, Lu, Wu, Hao, Zhang, Na, Wu, Shaochang, Fu, Chunpeng, Li, Xianxi, Yang, Ke, Tang, Tiancheng, Shen, Ruoxi, He, Lin, Huai, Cong, Qin, Shengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050705/
https://www.ncbi.nlm.nih.gov/pubmed/35484098
http://dx.doi.org/10.1038/s41398-022-01942-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050705/
https://www.ncbi.nlm.nih.gov/pubmed/35484098
http://dx.doi.org/10.1038/s41398-022-01942-w

Ejemplares similares